{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:24:56Z","timestamp":1786991096745,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271278"],"award-info":[{"award-number":["82271278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2020020601012303"],"award-info":[{"award-number":["2020020601012303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113087","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T06:50:56Z","timestamp":1725519056000},"page":"113087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PA","title":["NR1H4 ameliorates Parkinson\u2019s disease via inhibiting astrocyte activation and neuroinflammation in a CEBP\u03b2\/NF-\u03baB dependent manner"],"prefix":"10.1016","volume":"142","author":[{"given":"Jingwen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsha","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9423","key":"10.1016\/j.intimp.2024.113087_b0005","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113087_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105700","article-title":"Immune responses in the Parkinson's disease brain","volume":"168","author":"Weiss","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2024.113087_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"issue":"18","key":"10.1016\/j.intimp.2024.113087_b0020","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1007\/s00018-017-2513-1","article-title":"Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain","volume":"74","author":"Zhang","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.113087_b0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tins.2010.12.001","article-title":"Astrocyte-neuron metabolic relationships: For better and for worse","volume":"34","author":"Allaman","year":"2011","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.intimp.2024.113087_b0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrneurol.2017.69","article-title":"Modulators of microglial activation and polarization after intracerebral haemorrhage","volume":"13","author":"Lan","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.intimp.2024.113087_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107867","article-title":"The pathophysiological function of non-gastrointestinal farnesoid X receptor","volume":"226","author":"Yan","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2024.113087_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111616","article-title":"Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism","volume":"549","author":"Zhou","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"issue":"11","key":"10.1016\/j.intimp.2024.113087_b0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/13543776.2018.1527906","article-title":"FXR modulators for enterohepatic and metabolic diseases","volume":"28","author":"Wang","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2024.113087_b0055","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s12276-023-00932-2","article-title":"The role of the farnesoid X receptor in kidney health and disease: A potential therapeutic target in kidney diseases","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.113087_b0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yexcr.2018.07.004","article-title":"Effects of farnesoid-X-receptor SUMOylation mutation on myocardial ischemia\/reperfusion injury in mice","volume":"371","author":"Gao","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2024.113087_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111678","article-title":"Recent advances on FXR-targeting therapeutics","volume":"552","author":"Panzitt","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113087_b0070","first-page":"1403","article-title":"Farnesoid X receptor: A potential therapeutic target in multiple organs","volume":"35","author":"Zhang","year":"2020","journal-title":"Histol. Histopathol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113087_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101992","article-title":"Chenodeoxycholic Acid Ameliorates AlCl(3)-induced Alzheimer's disease neurotoxicity and cognitive deterioration via enhanced insulin signaling in rats","volume":"24","author":"Bazzari","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.intimp.2024.113087_b0080","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s11064-021-03303-3","article-title":"Ganoderic acid A attenuates LPS-induced neuroinflammation in BV2 microglia by activating Farnesoid X receptor","volume":"46","author":"Jia","year":"2021","journal-title":"Neurochem. Res."},{"issue":"7","key":"10.1016\/j.intimp.2024.113087_b0085","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/cns.14154","article-title":"Activation of the bile acid receptors TGR5 and FXR in the spinal dorsal horn alleviates neuropathic pain","volume":"29","author":"Wu","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"14","key":"10.1016\/j.intimp.2024.113087_b0090","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/WNR.0000000000001717","article-title":"Identification of the expression of farnesoid X receptor in astrocytes","volume":"32","author":"He","year":"2021","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41531-022-00352-5","article-title":"Melatonin ameliorates Parkinson's disease via regulating microglia polarization in a RORalpha-dependent pathway","volume":"8","author":"Li","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.intimp.2024.113087_b0105","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s11064-014-1443-7","article-title":"Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons","volume":"39","author":"Prakash","year":"2014","journal-title":"Neurochem. Res."},{"issue":"20","key":"10.1016\/j.intimp.2024.113087_b0110","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.7150\/thno.33872","article-title":"Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice","volume":"9","author":"Xian","year":"2019","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.intimp.2024.113087_b0115","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41418-019-0431-5","article-title":"Kidins220\/ARMS controls astrocyte calcium signaling and neuron-astrocyte communication","volume":"27","author":"Jaudon","year":"2020","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-022-02389-y","article-title":"Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT(2B)R\/beta-arrestin2 pathway","volume":"19","author":"Fang","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.intimp.2024.113087_b0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchemneu.2015.12.002","article-title":"Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model","volume":"71","author":"Rai","year":"2016","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.intimp.2024.113087_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchemneu.2016.11.009","article-title":"Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model","volume":"80","author":"Yadav","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.intimp.2024.113087_b0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbi.2023.11.035","article-title":"Sustainable inflammatory activation following spinal cord injury is driven by thrombin-mediated dynamic expression of astrocytic chemokines","volume":"116","author":"He","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"Pt 2","key":"10.1016\/j.intimp.2024.113087_b0140","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.freeradbiomed.2022.11.018","article-title":"Ferritin confers protection against iron-mediated neurotoxicity and ferroptosis through iron chelating mechanisms in MPP(+)-induced MES23.5 dopaminergic cells","volume":"193","author":"Zhang","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.113087_b0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S1461145708009243","article-title":"Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation","volume":"12","author":"Yang","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12974-020-01791-8","article-title":"Astragaloside IV inhibits astrocyte senescence: Implication in Parkinson's disease","volume":"17","author":"Xia","year":"2020","journal-title":"J. Neuroinflamm."},{"issue":"51","key":"10.1016\/j.intimp.2024.113087_b0155","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213041119","article-title":"FXR mediates ILC-intrinsic responses to intestinal inflammation","volume":"119","author":"Fu","year":"2022","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.113087_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114422","article-title":"Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism","volume":"185","author":"Jia","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12974-020-02018-6","article-title":"Sodium para-aminosalicylic acid inhibits manganese-induced NLRP3 inflammasome-dependent pyroptosis by inhibiting NF-kappaB pathway activation and oxidative stress","volume":"17","author":"Peng","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.intimp.2024.113087_b0170","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3389\/fimmu.2019.01043","article-title":"Cellular specificity of NF-kappaB function in the nervous system","volume":"10","author":"Dresselhaus","year":"2019","journal-title":"Front. Immunol."},{"issue":"7937","key":"10.1016\/j.intimp.2024.113087_b0175","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41586-022-05308-6","article-title":"Identification of environmental factors that promote intestinal inflammation","volume":"611","author":"Sanmarco","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.113087_b0180","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-023-03485-7","article-title":"Oral administration of silybin protects against MPTP-induced neurotoxicity by reducing pro-inflammatory cytokines and preserving BDNF levels in mice","author":"Ramirez-Carreto","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2024.113087_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154281","article-title":"Mangiferin, a natural glucoxilxanthone, inhibits mitochondrial dynamin-related protein 1 and relieves aberrant mitophagic proteins in mice model of Parkinson's disease","volume":"104","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2024.113087_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101752","article-title":"Advancement in the modelling and therapeutics of Parkinson's disease","volume":"104","author":"Rai","year":"2020","journal-title":"J. Chem. Neuroanat."},{"issue":"7638","key":"10.1016\/j.intimp.2024.113087_b0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.113087_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson's disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2024.113087_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109652","article-title":"Dopaminergic neuroprotective effects of inosine in MPTP-induced parkinsonian mice via brain-derived neurotrophic factor upregulation","volume":"238","author":"Khanal","year":"2023","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-023-02702-3","article-title":"Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology","volume":"20","author":"Stym-Popper","year":"2023","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.intimp.2024.113087_b0215","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/brain\/awaa457","article-title":"Glial cells and adaptive immunity in frontotemporal dementia with tau pathology","volume":"144","author":"Hartnell","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12974-023-02856-0","article-title":"Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes","volume":"20","author":"Yang","year":"2023","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0230","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-023-02884-w","article-title":"RGS5 augments astrocyte activation and facilitates neuroinflammation via TNF signaling","volume":"20","author":"Yin","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.intimp.2024.113087_b0235","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.redox.2013.12.013","article-title":"Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease","volume":"2","author":"Giordano","year":"2014","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113087_b0240","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.tips.2017.03.010","article-title":"Tipping points and endogenous determinants of nigrostriatal degeneration by MPTP","volume":"38","author":"Schildknecht","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2024.113087_b0245","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41419-022-05399-z","article-title":"Mitochondrial glutamine transporter SLC1A5_var, a potential target to suppress astrocyte reactivity in Parkinson's disease","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2024.113087_b0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2024.113087_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102299","article-title":"The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A review","volume":"97","author":"Hassani","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2024.113087_b0260","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.apsb.2022.07.021","article-title":"Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease","volume":"13","author":"Liu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0265","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12974-023-02989-2","article-title":"Targeting CB2R in astrocytes for Parkinson's disease therapy: Unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation","volume":"20","author":"Zhu","year":"2023","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40478-024-01782-3","article-title":"Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection","volume":"12","author":"Rombaut","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0275","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12974-023-02755-4","article-title":"NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models","volume":"20","author":"Liu","year":"2023","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.intimp.2024.113087_b0280","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1600-079X.2003.00107.x","article-title":"Effect of melatonin on temporal changes of reactive oxygen species and glutathione after MPP(+) treatment in human astrocytoma U373MG cells","volume":"36","author":"Chuang","year":"2004","journal-title":"J. Pineal Res."},{"issue":"26","key":"10.1016\/j.intimp.2024.113087_b0285","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.2174\/092986711796957266","article-title":"Advances in bile acid medicinal chemistry","volume":"18","author":"Sharma","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2024.113087_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/biom9060232","article-title":"The biosynthesis, signaling, and neurological functions of bile acids","volume":"9","author":"Kiriyama","year":"2019","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.intimp.2024.113087_b0295","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41401-021-00849-4","article-title":"FXR: Structures, biology, and drug development for NASH and fibrosis diseases","volume":"43","author":"Tian","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.intimp.2024.113087_b0300","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41419-021-03620-z","article-title":"The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD","volume":"12","author":"Kim","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113087_b0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1582-4934.2009.00997.x","article-title":"FXR an emerging therapeutic target for the treatment of atherosclerosis","volume":"14","author":"Mencarelli","year":"2010","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.113087_b0310","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.intimp.2024.113087_b0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2021.12.006","article-title":"Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation","volume":"28","author":"Thibaut","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.113087_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102530","article-title":"The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice","volume":"298","author":"Wang","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2024.113087_b0325","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2024.113087_b0330","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fnbeh.2015.00070","article-title":"Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior","volume":"9","author":"Huang","year":"2015","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113087_b0335","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","article-title":"Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis","volume":"25","author":"Hao","year":"2017","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.intimp.2024.113087_b0340","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/toxsci\/kfaa111","article-title":"Regulation of lung macrophage activation and oxidative stress following ozone exposure by farnesoid X receptor","volume":"177","author":"Francis","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"22","key":"10.1016\/j.intimp.2024.113087_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214254","article-title":"Liver steatosis and steatohepatitis alter bile acid receptors in brain and induce neuroinflammation: A contribution of circulating bile acids and blood-brain barrier","volume":"23","author":"Fiaschini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113087_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114561","article-title":"Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity","volume":"188","author":"Bao","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113087_b0355","doi-asserted-by":"crossref","DOI":"10.1093\/procel\/pwae016","article-title":"Gut dysbiosis impairs intestinal renewal and lipid absorption in Scarb2 deficiency-associated neurodegeneration","author":"Li","year":"2024","journal-title":"Protein Cell"},{"issue":"7","key":"10.1016\/j.intimp.2024.113087_b0360","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302416","article-title":"Nr1h4 and Thrb ameliorate ER stress and provide protection in the MPTP mouse model of Parkinson's","volume":"7","author":"Ahuja","year":"2024","journal-title":"Life Sci. Alliance"},{"issue":"11","key":"10.1016\/j.intimp.2024.113087_b0365","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113087_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/diseases11030089","article-title":"WNT-beta catenin signaling as a potential therapeutic target for neurodegenerative diseases: Current status and future perspective","volume":"11","author":"Ramakrishna","year":"2023","journal-title":"Diseases"},{"issue":"12","key":"10.1016\/j.intimp.2024.113087_b0375","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.cellsig.2009.08.009","article-title":"C\/EBPbeta enhances NF-kappaB-associated signalling by reducing the level of IkappaB-alpha","volume":"21","author":"Cappello","year":"2009","journal-title":"Cell. Signal."},{"issue":"43","key":"10.1016\/j.intimp.2024.113087_b0380","doi-asserted-by":"crossref","first-page":"33092","DOI":"10.1074\/jbc.M110.130377","article-title":"CCAAT\/enhancer-binding protein beta and NF-kappaB mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1beta","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113087_b0385","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2014.03.007","article-title":"C\/EBPbeta knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFkappaB","volume":"390","author":"Zou","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0390","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s40425-019-0701-2","article-title":"Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1\/CEBPB\/NF-kappaB signaling","volume":"7","author":"Wang","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2024.113087_b0395","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.biopha.2017.11.092","article-title":"Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C\/EBPbeta\/NF-kappaB signaling","volume":"96","author":"Yang","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.intimp.2024.113087_b0400","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson's disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113087_b0405","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.intimp.2024.113087_b0410","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113087_b0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276717","article-title":"Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice","volume":"17","author":"Liu","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.intimp.2024.113087_b0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083807","article-title":"Obeticholic acid derivative, T-2054 suppresses osteoarthritis via inhibiting NF-kappaB-signaling pathway","volume":"22","author":"Guo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0425","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1681\/ASN.2017020222","article-title":"FXR\/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity","volume":"29","author":"Wang","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113087_b0430","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030940","article-title":"Obeticholic acid inhibits anxiety via alleviating gut microbiota-mediated microglia accumulation in the brain of high-fat high-sugar diet mice","volume":"13","author":"Wu","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.intimp.2024.113087_b0435","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajpath.2022.09.005","article-title":"Anti-cholestatic therapy with obeticholic acid improves short-term memory in bile duct-ligated mice","volume":"193","author":"Gee","year":"2023","journal-title":"Am. J. Pathol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924016084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924016084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:10:38Z","timestamp":1777619438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924016084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":87,"alternative-id":["S1567576924016084"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113087","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NR1H4 ameliorates Parkinson\u2019s disease via inhibiting astrocyte activation and neuroinflammation in a CEBP\u03b2\/NF-\u03baB dependent manner","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113087"}}